Psoriasis Current Events | Psoriasis News | 2
|
|
|
Sort By:
Page Views | Date |
Home UVB therapy for psoriasis as effective and safe as hospital treatment
For patients with psoriasis, treatment with ultraviolet B (UVB) at home is as effective and as safe as conventional hospital based phototherapy, concludes a study published on bmj.com today. view more (2009-05-08)
Short-term topical corticosteroid use may offer relief for patients with acute form of psoriasis
Researchers suggest a short-term application of topical corticosteroids and maintenance with a less potent agent for patients with intertriginous psoriasis (IP). view more (2006-09-19)
Researchers identify 4 genetic hotspots associated with psoriasis
A genomewide scan of millions of genetic mutations has revealed four new DNA "hotspots" that affect the risk for psoriasis, a national group of researchers led by the University of Michigan and including several from the University of Utah School of Medicine has shown in a just-published study. view more (2009-01-27)
'Allergy cells' can aggravate cancer and psoriasis
The body's mast cells are mainly associated with allergic reaction in the way they release histamine and other inflammatory substances. view more (2006-09-11)
Green tea holds promise as new treatment for inflammatory skin diseases
Green tea could hold promise as a new treatment for skin disorders such as psoriasis and dandruff, Medical College of Georgia researchers say. view more (2007-08-07)
Possible New Cure for Psoriasis
Cell biologists of the University of Bonn, in cooperation with the University of Leeds (U.K.) and industry may have discovered a new effective therapy for psoriasis: a specific group of what are known as metalloproteinase inhibitors can normalise the increased tendency of epidermis cells (keratinocytes) to divide, which is the cause of this... view more... (2004-08-16)
U-M scientists identify major psoriasis susceptibility gene
University of Michigan scientists have found a common genetic variation in an immune system gene that makes people much more likely to develop psoriasis - a disfiguring inflammatory skin disease. view more (2006-03-16)
Investigational study of ustekinumab in the treatment of psoriatic arthritis published
A group of patients suffering from potentially debilitating psoriatic arthritis showed significant and prolonged improvement after treatment with ustekinumab, according to data from a randomized, double-blind, placebo-controlled study in patients with moderate to severe psoriatic arthritis (PsA). view more (2009-02-12)
First international guidelines for treatment of psoriatic arthritis
Rheumatologists, dermatologists, and patient advocates have come together to publish the first-ever international guidelines for the treatment of psoriatic arthritis, a disease that mainly affects people who have psoriasis but also some people without it. view more (2008-10-27)
Ustekinumab Phase 3 data show long-term improvement of chronic plaque psoriasis
One-year data from a second double-blind, placebo-controlled Phase 3 study showed therapy with ustekinumab given every 12 weeks provided sustained, clinically meaningful improvement in the treatment of moderate to severe plaque psoriasis through one year. view more (2008-02-04)
Remicade therapy shown to improve productivity in patients treated for chronic plaque psoriasis
Investigators reported today at the American Academy of Dermatology annual meeting that patients with moderate to severe plaque psoriasis receiving REMICADE® (infliximab) induction and maintenance therapy experienced significant improvements in productivity at week 10, which were sustained through week 50. view more (2007-02-05)
NICE gives backing for the use of advanced biological therapies to treat severe psoriasis
The UK National Institute for Health and Clinical Excellence (NICE) has today issued guidance for the use of the targeted biological therapies, Enbrel® (etanercept) and Raptiva® (efalizumab), to treat adult patients with severe plaque psoriasis. view more (2006-07-27)
New findings show Enbrel significantly reduced levels of C-reactive protein
Amgen (NASDAQ: AMGN) and Wyeth Pharmaceuticals, a division of Wyeth (NYSE: WYE), today announced findings from a retrospective analysis, which demonstrated that ENBREL reduced C-reactive protein (CRP), a marker of inflammation, in patients with moderate to severe plaque psoriasis following 12 weeks of treatment. view more (2008-02-04)
New analyses reinforce efficacy of Remicade in treatment of severe psoriasis
Findings from an integrated analysis of data from three pivotal, randomized, placebo-controlled trials showed that at week 10 more than three-quarters of patients with severe psoriasis receiving REMICADE® (infliximab) 3 mg/kg or 5 mg/kg achieved a 75 percent improvement in the chronic, inflammatory skin disease as measured by the Psoriasis... view more... (2007-02-05)
Genetic finding suggests alternative treatment strategy for common, complex skin disorders
A genetic finding by researchers at the National Institutes of Health provides new insight into the cause of a series of related, common and complex illnesses - including hay fever and asthma as well as the skin disorders eczema and psoriasis - and suggests a novel therapeutic approach. view more (2006-04-26)
Drug rescues memory lost to Alzheimer's disease
A drug similar to one used in clinical trials for treatment of rheumatoid arthritis and psoriasis has been found to rescue memory in mice exhibiting Alzheimer's symptoms. view more (2009-07-15)
M.D. Anderson-led team reports possible key to autoimmune disease
A human peptide that acts as a natural antibiotic against invading microbes can also bind to the body's own DNA and trigger an immune response in the absence of an infection, a research team led by scientists at The University of Texas M. D. Anderson Cancer Center reports in an early online publication in Nature. view more (2007-09-17)
Green tea may delay onset of type 1 diabetes
A powerful antioxidant in green tea may prevent or delay the onset of type 1 diabetes, Medical College of Georgia researchers say. view more (2008-10-24)
Schizophrenia drugs increase risk of cardiac arrest
Patients with schizophrenia who take antipsychotic drugs are more likely to have a cardiac arrest than non-schizophrenic patients, finds a study in this week’s BMJ. view more (2002-11-06)
Curry-cure? Spicing up the effectiveness of a potential disease-fighter
Scientists are reporting development of a nano-size capsule that boosts the body's uptake of curcumin, an ingredient in yellow curry now being evaluated in clinical trials for treatment of several diseases. view more (2009-11-05)
|
|
|
|
Sort By:
Page Views | Date |
|
